ResMed Inc (RMD)
Current ratio
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 3,505,600 | 3,208,420 | 2,836,180 | 2,641,120 | 2,357,720 | 2,351,300 | 2,378,080 | 2,304,580 | 2,367,830 | 2,337,820 | 2,325,160 | 2,033,700 | 1,931,480 | 1,704,300 | 1,547,240 | 1,586,260 | 1,574,760 | 1,466,150 | 1,451,480 | 1,542,610 |
Total current liabilities | US$ in thousands | 1,019,120 | 940,516 | 851,960 | 904,079 | 910,655 | 773,030 | 764,073 | 770,802 | 758,533 | 761,691 | 732,714 | 692,659 | 689,299 | 667,265 | 621,064 | 624,158 | 911,766 | 876,541 | 577,335 | 590,853 |
Current ratio | 3.44 | 3.41 | 3.33 | 2.92 | 2.59 | 3.04 | 3.11 | 2.99 | 3.12 | 3.07 | 3.17 | 2.94 | 2.80 | 2.55 | 2.49 | 2.54 | 1.73 | 1.67 | 2.51 | 2.61 |
June 30, 2025 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,505,600K ÷ $1,019,120K
= 3.44
The current ratio of ResMed Inc. demonstrates a generally stable liquidity position over the analyzed period, with some fluctuations. At the start of the period, as of September 30, 2020, the current ratio stood at 2.61, indicating that current assets were approximately 2.61 times greater than current liabilities, signifying a comfortable liquidity cushion. This ratio experienced a slight decline by December 31, 2020, decreasing to 2.51, but remained within a robust range.
Throughout 2021, the current ratio exhibited a downward trend, reaching a low of 1.67 on March 31, 2021. This could suggest a temporary reduction in liquidity or a change in the composition of current assets and liabilities. However, the ratio recovered subsequently, rising back to 2.54 by September 30, 2021, and maintaining strength through the remainder of 2021, with ratios around 2.49 to 2.55.
In 2022, the current ratio continued to improve, reaching 2.80 by June 30, and further increasing to 2.94 by September 30. This upward trend indicates enhanced liquidity and possibly better short-term asset management or controlled liabilities growth. The ratio peaked at 3.17 at the close of 2022, reflecting a solid liquidity position.
The first half of 2023 saw the ratio remaining above 3.0, with 3.07 at the end of March and 3.12 in June, suggesting strong liquidity levels. Slight fluctuations occurred, with a minor decrease to 2.99 in September 2023, but the ratio remained comfortably above typical minimum benchmarks. As of December 31, 2023, the ratio increased again to 3.11.
In early 2024, the ratio decreased slightly to 3.04 in March but then declined further to 2.59 by June 30. Nonetheless, the ratio rebounded to 2.92 as of September 30, 2024, and increased significantly through late 2024 and into 2025, reaching 3.33 in December 2024, and an even higher 3.41 as of March 31, 2025. The ratio further increased to 3.44 by June 30, 2025, indicating a consistent and healthy liquidity buffer in recent periods.
Overall, the trend of ResMed Inc.'s current ratio reflects stability with periods of fluctuation, but generally maintains a position well above the commonly accepted threshold of 1.0, indicating a prudent liquidity management approach and a strong ability to meet short-term obligations. The ratio's upward trajectory toward the latter part of the observed timeline suggests an overall strengthening of the company's liquidity position.
Peer comparison
Jun 30, 2025